Fonterra Bets on Biotech to Future-Proof Dairy
Source: dairynews.today
Fonterra's Ki Tua fund supports global biotech to innovate dairy, focusing on gut health and advanced protein extraction.
Fonterra is leveraging its Ki Tua fund to stay ahead in the biotech industry, supporting innovative techniques from gut microbiomes to light-controlled proteins. "Ki Tua means 'to go beyond,' underscoring Fonterra's commitment to competitiveness in a rapidly-evolving market," said Komal Mistry-Mehta, the managing director. Under her leadership, the fund evaluates over 100 companies monthly, selecting only those that offer productivity improvement, climate challenge solutions, or nutritional enhancement.
Noteworthy investments include Calgary's Nimble Science and Sydney's Swan Genomics, illustrating Ki Tua's broad reach. Fonterra aims for strategic partnerships and minority investments to drive long-term value, as demonstrated by its $1.8 million stake in BioLumic, a company that enhances ryegrass. This strategic approach positions Fonterra to lead the next wave of dairy science.
Noteworthy investments include Calgary's Nimble Science and Sydney's Swan Genomics, illustrating Ki Tua's broad reach. Fonterra aims for strategic partnerships and minority investments to drive long-term value, as demonstrated by its $1.8 million stake in BioLumic, a company that enhances ryegrass. This strategic approach positions Fonterra to lead the next wave of dairy science.
Key News of the Week
